Phathom Pharmaceuticals (PHAT) Research & Development (2022 - 2025)
Historic Research & Development for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Q3 2025 value amounting to $7.0 million.
- Phathom Pharmaceuticals' Research & Development fell 1916.48% to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.9 million, marking a year-over-year decrease of 1291.49%. This contributed to the annual value of $34.1 million for FY2024, which is 3169.8% down from last year.
- Per Phathom Pharmaceuticals' latest filing, its Research & Development stood at $7.0 million for Q3 2025, which was down 1916.48% from $9.1 million recorded in Q2 2025.
- In the past 5 years, Phathom Pharmaceuticals' Research & Development registered a high of $19.0 million during Q3 2022, and its lowest value of $7.0 million during Q3 2025.
- Its 4-year average for Research & Development is $12.0 million, with a median of $11.5 million in 2023.
- Per our database at Business Quant, Phathom Pharmaceuticals' Research & Development plummeted by 4221.25% in 2024 and then surged by 2304.77% in 2025.
- Over the past 4 years, Phathom Pharmaceuticals' Research & Development (Quarter) stood at $15.9 million in 2022, then dropped by 16.0% to $13.4 million in 2023, then plummeted by 35.92% to $8.6 million in 2024, then fell by 18.13% to $7.0 million in 2025.
- Its Research & Development was $7.0 million in Q3 2025, compared to $9.1 million in Q2 2025 and $9.2 million in Q1 2025.